BUB1B and lung adenocarcinoma: We found that while BUB1B was overexpressed in 72% (351/489) of tumors compared to normal lung tissue, only 2.6% had somatic mutations and amplifications were rare, suggesting that BUB1B overexpression in human lung adenocarcinomas is likely to be regulated either transcriptionally or post-transcriptionally.